{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:50:29Z","timestamp":1790383829485,"version":"4.1.0"},"reference-count":34,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"published-print":{"date-parts":[[2025,3,26]]},"abstract":"<jats:sec><jats:title>Introduction:<\/jats:title><jats:p> Treatment of acute bacterial skin and skin structure infections (ABSSSIs) with intravenous (IV) antibiotics is difficult in marginalized populations, such as people who inject drugs, due to issues such as unstable housing or mental health conditions. These factors often require extended hospital admissions for IV antibiotics. Dalbavancin, a novel lipoglycopeptide antibiotic effective against gram-positive bacteria, lasts over 14 days and may be suitable for patients who struggle with traditional IV antibiotic administration. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p> This was a case series in which we reviewed 19 patients referred to our cellulitis clinic in London, Ontario, Canada, between February 1 and July 30, 2023, who received a single dose of IV dalbavancin for ABSSSIs as out-patients. Those who were enrolled had severe infections requiring IV antibiotics, with psychosocial factors pre-cluding out-patient IV therapy, or were at high risk of non-adherence to oral antibiotics. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p> The median age of patients was 43 (range 36\u201356 years); they were mostly male (74%), unemployed (89%), and with unstable housing (58%). Positive outcomes were observed in 13 out of 19 (68%) patients; 3 out of 19 had indeterminate outcomes (could not be reached for follow-up but were not admitted to any institution within our catchment area) and 3 out of 19 had negative outcomes (needed further antibiotics following dalbavancin). <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p> Our experience shows that a single IV dose of dalbavancin is effective in treating ABSSSIs in patients with complex psychosocial factors, as positive outcomes were observed in most patients. Dalbavancin eliminates the need for indwelling IV access and may reduce hospital admissions for patients for whom traditional antibiotic regimens may be challenging. <\/jats:p><\/jats:sec>","DOI":"10.3138\/jammi-2024-0015","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T14:33:01Z","timestamp":1738247581000},"page":"40-52","source":"Crossref","is-referenced-by-count":2,"title":["Use of dalbavancin in treatment of acute bacterial skin and skin structure infections: Case series from a Canadian perspective"],"prefix":"10.3138","volume":"10","author":[{"given":"Wayne","family":"Leung","sequence":"first","affiliation":[{"name":"London Health Sciences Centre, Infectious Diseases, London, Ontario, Canada"},{"name":"Western University, Schulich School of Medicine, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janhavi","family":"Bhalla","sequence":"additional","affiliation":[{"name":"Western University, Schulich School of Medicine, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Ataie","sequence":"additional","affiliation":[{"name":"Western University, Schulich School of Medicine, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Elsayed","sequence":"additional","affiliation":[{"name":"Western University, Schulich School of Medicine, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Bondy","sequence":"additional","affiliation":[{"name":"Western University, Schulich School of Medicine, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Devlin","sequence":"additional","affiliation":[{"name":"Western University, Schulich School of Medicine, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Shalhoub","sequence":"additional","affiliation":[{"name":"Western University, Schulich School of Medicine, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huma","family":"Saeed","sequence":"additional","affiliation":[{"name":"Western University, Schulich School of Medicine, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid","family":"Mohammadi","sequence":"additional","affiliation":[{"name":"Western University, Schulich School of Medicine, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Silverman","sequence":"additional","affiliation":[{"name":"Western University, Schulich School of Medicine, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza Rahimi","family":"Shahmirzadi","sequence":"additional","affiliation":[{"name":"Western University, Schulich School of Medicine, London, Ontario, Canada"},{"name":"Infectious Diseases Care Program, St. Joseph's Hospital, London, Ontario, Canada"},{"name":"Correspondence: Reza Rahimi Shahmirzadi, Infectious Diseases Care Program St. Joseph's Hospital 268 Grosvenor Street, London, Ontario N6A 4V2 Canada. Telephone: (519) 646-6207."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1696","reference":[{"key":"r1","volume-title":"Guidance for Industry Acute Bacterial Skin and Skin Structure Infections: Developing Drugs for Treatment","author":"US Department of Health and Human Services","year":"2013"},{"issue":"2","key":"r2","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","volume":"59","author":"Stevens DL","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2","key":"r3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/QCO.0000000000000906","volume":"36","author":"Bouza E","year":"2023","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"r4","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1093\/cid\/ciz004","volume":"68","author":"Golan Y","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"r5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40121-019-0247-0","volume":"8","author":"Bork JT","year":"2019","journal-title":"Infect Dis Ther"},{"issue":"1","key":"r6","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/ofid\/ofy270","volume":"6","author":"Diekema DJ","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"r7","doi-asserted-by":"crossref","first-page":"114881","DOI":"10.1016\/j.diagmicrobio.2019.114881","volume":"95","author":"Stefaniuk EM","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"r8","doi-asserted-by":"crossref","first-page":"115195","DOI":"10.1016\/j.diagmicrobio.2020.115195","volume":"99","author":"Sader HS","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"23","key":"r9","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1310480","volume":"370","author":"Boucher HW","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"r10","doi-asserted-by":"crossref","first-page":"ofx102","DOI":"10.1093\/ofid\/ofx102","volume":"4","author":"Buehrle DJ","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"r11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.diagmicrobio.2016.12.015","volume":"87","author":"Jain SR","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"r12","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1128\/AAC.00377-07","volume":"51","author":"Rajendran PM","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"r13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.inf.0000109288.06912.21","volume":"23","author":"Lee MC","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"r14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.annemergmed.2009.03.014","volume":"55","author":"Duong M","year":"2010","journal-title":"Ann Emerg Med"},{"issue":"1","key":"r15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7326\/M18-2124","volume":"170","author":"Schranz AJ","year":"2019","journal-title":"Ann Intern Med"},{"issue":"4","key":"r16","doi-asserted-by":"crossref","first-page":"ofz089","DOI":"10.1093\/ofid\/ofz089","volume":"6","author":"Leahey PA","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"r17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cid\/ciz869","volume":"71","author":"Straw S","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"r18","doi-asserted-by":"crossref","first-page":"e2012974","DOI":"10.1001\/jamanetworkopen.2020.12974","volume":"3","author":"Tan C","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"r19","doi-asserted-by":"crossref","first-page":"dlaa113","DOI":"10.1093\/jacamr\/dlaa113","volume":"3","author":"Grattan KS","year":"2021","journal-title":"JAC Antimicrob Resist"},{"issue":"3","key":"r20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/cid\/ciac714","volume":"76","author":"Wildenthal JA","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"1","key":"r21","doi-asserted-by":"crossref","first-page":"ofad005","DOI":"10.1093\/ofid\/ofad005","volume":"10","author":"Yang WT","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"r22","doi-asserted-by":"crossref","first-page":"ofab629","DOI":"10.1093\/ofid\/ofab629","volume":"9","author":"Gelman SS","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"r23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/08897077.2018.1452326","volume":"39","author":"Englander H","year":"2018","journal-title":"Subst Abus"},{"issue":"2","key":"r24","doi-asserted-by":"crossref","first-page":"ofac492.843","DOI":"10.1093\/ofid\/ofac492.843","volume":"9","author":"Juskowich JJ","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"r25","unstructured":"Naved Altaf - Quality Management and Clinical Decision Support (X 64014). Integrated Decision Support (IDS) - DAD (Discharge Abstract Database)."},{"issue":"1","key":"r26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s40121-021-00402-0","volume":"10","author":"Gonzalez PL","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"3","key":"r27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1086\/427283","volume":"40","author":"Raad I","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"r28","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/antibiotics12050928","volume":"12","author":"Gostev V","year":"2023","journal-title":"Antibiotics"},{"issue":"4","key":"r29","doi-asserted-by":"crossref","first-page":"429.e1","DOI":"10.1016\/j.cmi.2017.07.028","volume":"24","author":"Werth BJ","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"r30","unstructured":"Spectrum Mobile Health Inc., dba Firstline Clinical. All rights reserved."},{"issue":"1","key":"r31","doi-asserted-by":"crossref","first-page":"ofy331","DOI":"10.1093\/ofid\/ofy331","volume":"6","author":"Rappo U","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"r32","doi-asserted-by":"crossref","first-page":"ofad500.173","DOI":"10.1093\/ofid\/ofad500.173","volume":"10","author":"Sanikommu S","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"r33","doi-asserted-by":"crossref","first-page":"ofad500.025","DOI":"10.1093\/ofid\/ofad500.025","volume":"10","author":"Zambrano S","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"r34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2147\/TCRM.S271445","volume":"17","author":"Simonetti O","year":"2021","journal-title":"Ther Clin Risk Manag"}],"container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/jammi-2024-0015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:22:18Z","timestamp":1746710538000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/jammi-2024-0015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3,26]]}},"alternative-id":["10.3138\/jammi-2024-0015"],"URL":"https:\/\/doi.org\/10.3138\/jammi-2024-0015","relation":{},"ISSN":["2371-0888"],"issn-type":[{"value":"2371-0888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]}}}